Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$2.95 - $11.04 $734 - $2,748
-249 Reduced 1.65%
14,848 $88,000
Q3 2020

Nov 12, 2020

BUY
$9.37 - $12.06 $609 - $783
65 Added 0.43%
15,097 $163,000
Q2 2020

Aug 12, 2020

BUY
$8.29 - $11.47 $124,615 - $172,417
15,032 New
15,032 $161,000

About AVENUE THERAPEUTICS, INC.


  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $9.25M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.